Work

Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.

Year: 2006

Type: article

Source: PubMed

Author: Patrizia Marini

Institution: University of Tübingen

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W149908027

FWCI: 0.901

Cites:

Cited by: 22

Related to: 10